ADD ANYTHING HERE OR JUST REMOVE IT…
Wrong menu selected
Acarix Acarix
  • Product

    Background

    • What is Coronary Artery Disease (CAD)?
    • Diagnosing CAD

    About the product

    • The CADScor® System
    • How does it work
  • Resources

    Testimonials

    • HCP stories
    • Patient stories

    References

    • Clinical Studies
    • Downloads (US)
    • Downloads (EU)

    Support

    • Training
    • FAQ
    • Reimbursement

    Physician Locator

    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Rights Issue/Warrant Program
    • Previous Rights Issue
    • Investor Presentations
  • Company

    Who we are

    • About Acarix
    • leadership
    • Join the team

    Get in touch

    • Contact us
    • Investigator Initiated Study
  • News
    • News
    • Press
    • Events
    • Social Media
Search
Book a Demo
Acarix Acarix
Book a demo
Menu
author-avatar acarix
Press
August 6, 2024
01 Apr 2022

FDA begär kompletterande information för Acarix ansökan om Breakthrough Designation-status för diagnos av hjärtsvikt

Pressmeddelande (MAR)Malmö, Sverige, 1 april 2022   FDA begär kompletterande information för Acarix ansökan om Breakthrough Designat...
Continue reading
author-avatar acarix
Press
August 6, 2024
11 Mar 2022

Acarix receives strategic order for the CADScor®System in US

Press release (MAR)Malmö, Sweden, March 11, 2022   Acarix receives strategic order for the CADScor®System in US Acarix today announce...
Continue reading
author-avatar acarix
Press
August 6, 2024
11 Mar 2022

Acarix erhåller strategisk order av CADScor®System i USA

Pressmeddelande (MAR)Malmö, 11 mars 2022   Acarix erhåller strategisk order av CADScor®System i USA Acarix meddelar idag att man vunn...
Continue reading
author-avatar acarix
Press
August 6, 2024
10 Mar 2022

Acarix presents at the Redeye Artificial Intelligence Seminar 2022

Press release Malmö, Sweden, March 10, 2022   Acarix presents at the Redeye Artificial Intelligence Seminar 2022 On March 16 at 1.50p...
Continue reading
author-avatar acarix
Press
August 6, 2024
10 Mar 2022

Acarix presenterar vid Redeye seminarium om artificiell intelligens 2022

Pressmeddelande Malmö, 10 mars 2022   Acarix presenterar vid Redeye seminarium om artificiell intelligens 2022. Den 16 mars kl. 13.50...
Continue reading
author-avatar acarix
Press
August 6, 2024
18 Feb 2022

Acarix kapitalmarknadsdag: Uppdatering kring strategi, marknader och målsättningar

Pressmeddelande Malmö, 18 februari 2022   Acarix kapitalmarknadsdag: Uppdatering kring strategi, marknader och målsättningar  Vid...
Continue reading
author-avatar acarix
Press
August 6, 2024
17 Feb 2022

Rättelse av Pressmeddelande: Acarix AB (publ) publicerar Bokslutskommuniké 2021

Pressmeddelande Malmö, 17 februari 2022   Rättelse av Pressmeddelande: Acarix AB (publ) publicerar Bokslutskommuniké 2021 Det pressme...
Continue reading
author-avatar acarix
Press
August 6, 2024
17 Feb 2022

Correction of press release: Acarix AB (publ) publishes Year-End Report 2021

Press release Malmö, Sweden, February 17, 2022   Correction of press release: Acarix AB (publ) publishes Year-End Report 2021 The pre...
Continue reading
author-avatar acarix
Press
August 6, 2024
17 Feb 2022

Acarix AB (publ) publicerar Bokslutskommuniké 2021

Pressmeddelande Malmö, 17 februari 2022   Acarix AB (publ) publicerar Bokslutskommuniké 2021 Grunden är lagd för en accelererad expan...
Continue reading
author-avatar acarix
Press
August 6, 2024
17 Feb 2022

Acarix AB (publ) publishes Year-End Report 2021

Press release Malmö, Sweden, February 17, 2022   Acarix AB (publ) publishes Year-End Report 2021 Groundwork laid for accelerated expa...
Continue reading
author-avatar acarix
Press
August 6, 2024
09 Feb 2022

Acarix lämnar in ansökan om status som Breakthrough Therapy till FDA vid diagnosen hjärtsvikt

Pressmeddelande Malmö, 9 februari 2022   Acarix lämnar in ansökan om status som Breakthrough Therapy till FDA vid diagnosen hjärtsvikt...
Continue reading
author-avatar acarix
Press
August 6, 2024
09 Feb 2022

Acarix submits breakthrough designation request with FDA for heart failure diagnosis

Press release Malmö, Sweden, February 9, 2022   Acarix submits breakthrough designation request with FDA for heart failure diagnosis  ...
Continue reading
  • «
  • ‹
  • 17
  • 18
  • 19
  • 20
  • 21
  • ›
  • »
Acarix AB
Jungmansgatan 12
211 19 Malmö
SE
[email protected]

Product

Background

  • What is Coronary Artery Disease (CAD)?
  • Diagnosing CAD

About the product

  • The CADScor® System
  • How does it work

Resources

Testimonials

  • HCP stories
  • Patient stories

Support

  • Training
  • FAQ

References

  • Clinical Studies
  • Downloads (US)
  • Downloads (EU)

Investors

  • Corporate Governance
  • General Meetings
  • Financial Reports and Calendar
  • The Acarix Share
  • Rights Issue
  • Investor Presentations

Company

Who we are

  • About Acarix
  • Management
  • Join the team

Get in touch

  • Contact us
  • LinkedIn
  • Twitter

News

  • News
  • Press
  • Events
  • Cookie policy
  • Full Disclaimer
  • Privacy Policy: Clinical Studies
  • Privacy Policy
  • Cookie policy
  • Full Disclaimer
  • Privacy Policy: Clinical Studies
  • Privacy Policy

Acarix, 2023. All rights reserved V5

  • Products
    • Background
      • What is Coronary Artery Disease
      • Diagnosing CAD
    • About the product
      • The Cadscor System
      • How Does it Work
  • Resources
    • Testimonial
      • HCP Stories
      • Patients Stories
    • References
      • Clinical Studies
      • Downloads (US)
      • Downloads (EU)
    • Support
      • Training
      • Faq
      • Reimbursement
    • Physician Locator
      • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Right Issue
    • Previous Rights Issue
    • Investor Presentations
  • Company
    • Who we are
      • About Acarix
      • Leadership
      • Join The Team
    • Get in touch
      • Contact Us
      • Investigator Initiated Study
  • News
    • News
    • Press
    • Events
    • Socialmedia
Start typing to see products you are looking for.